New in PrepQ: patients complete pre visit intake by text. They answer screening questions and upload MRI photos or screenshots right from their phone. Staff copy it all into the chart in seconds. Works with any EMR. No integration required. prepq.health
Keith Schmidt, MD retweeted
"Saas is dead because customers can vibe-code their own tools."
People can cook. Restaurants still exist.
This could be a reason why high doses of vitamin C are recommended as prophylaxis to patients with CRPS to prevent a worsening of symptoms with surgery.
Vitamin C completely prevents rise in cortisol in stress study.
More evidence for the anti-cortisol / anti-stress properties of high doses of vitamin C.
Animals given a 500-700 mg human equivalent of C had no elevation in cortisol in response to stress.
The adrenals concentrate vitamin C more than just about any other tissue, and appear to use it to regulate cortisol synthesis.
Keith Schmidt, MD retweeted
Prolonged tadalafil exposure promotes skeletal muscle myogenesis and regulates early myogenic markers activation in C2C12 cell lines
“emerging evidence suggests that phosphodiesterase type 5 (PDE5) inhibitors may also have an effect on skeletal muscle metabolism and plasticity…”
pubmed.ncbi.nlm.nih.gov/4285…
Keith Schmidt, MD retweeted
neuroscientists discovered your brain believes whatever you think on repeat, and it doesn't care if it's true.
Readers added context they thought people might want to know
The cited 2021 paper studied the illusory truth effect: people rate externally repeated statements as more true because they become easier to process. It did not find that the brain automatically believes whatever you think internally on repeat, or that truth is irrelevant. pmc.ncbi.nlm.nih.gov
Keith Schmidt, MD retweeted
Fasting meets ITOA. New review by Valter Longo et al
sciencedirect.com/science/ar…
Keith Schmidt, MD retweeted
Daily reminder that ChatGPT and Claude are literally PAYING you to use them (user acquisition).
A $200 sub has an API-equivalent of $8k-$14k per month.
Meaning they're LOSING money to fund your tokens.
AI will never be this cheap. This isn't sustainable forever.
Build. Now.
Keith Schmidt, MD retweeted
Using GPT Astra 6 to make an intubation training simulation, something every model (including Fable) has failed at before. It is really, really good at visiospatial work. Will open source this soon.
PrepQ is live on the App Store.
Patients ask the same things before every procedure. When do I stop eating? Do I hold my blood thinner? Who drives me home?
Those questions come at 9pm, not during clinic hours. Unanswered, they turn into day of surgery cancellations and wasted OR time.
PrepQ answers them by text and voice, around the clock, using content your practice wrote and approved. Not generic AI. Your answers.
Built by two board certified physicians who got tired of losing procedures to preventable prep failures.
Live today, with our first paying practices onboard!
#MedTwitter #HealthTech #DigitalHealth
Website 💻 prepq.health
4
48
Keith Schmidt, MD retweeted
proof the FDA became a bio/acc ally in 2026
- peptides → approved
- CRISPR → approved
- mRNA → approved
- iPSC therapies → moving into humans
- psychedelics → formal FDA development guidance
- genome editing → new platform guidance
- clinical trials → new programs to cut development time
we've got the regulator literally building the rails for frontier bio
bio/acc
Keith Schmidt, MD retweeted
A study with almost 74,000 subjects ages 50-85.
Conclusion:
-The wealthiest Americans had approximately the same survival rates as the poorest people in Europe.
Wealth helps enormously within the United States, but even high wealth does not completely overcome the US–European mortality disadvantage.
Wealthy Americans presumably have much greater ability to buy excellent medical care, better housing, healthier food, gyms, preventive testing and so forth. Yet their survival remained roughly comparable to the poorest group in Northern/Western Europe.
The study doesn’t provide direct answers to why this happens. However, maybe wealth cannot outperform lifestyle, strong social safety net, great food around friends and family, lower stress, walking significantly more everyday to your bakery (yes, believe it or not, Europeans are big on bread), local food stores, coffee shops, affording to retire when it is time without worrying about paying bills especially when you get sick…
As both an American and European citizen, I believe it may be time for Americans to recalibrate how we think about longevity.
We are increasingly chasing the latest intervention such as rapamycin, peptides, cold plunges, red-light therapy…hoping that targeting a single enzyme or metabolic pathway will move the needle.
As a systems physiologist, I struggle with that view. Human physiology is not a collection of isolated pathways. Trillions of cells communicate across metabolic, vascular, endocrine, immune and neurological systems. Health emerges from their integration.
Perhaps longevity is less about hacking individual pathways and more about creating the environment in which the whole organism can thrive.
Between July 16 and August 6, @FDA approved five medicines that had never existed before. Not five new drugs. Five firsts.
1. The first mRNA flu vaccine. Moderna’s mFlusiva, approved August 5 for adults 50 and up. In a trial of 40,805 people, it was 26.6% more effective than a standard flu shot. The technology that made the COVID vaccines now covers the flu.
2. The first drug that treats the cause of narcolepsy. Takeda’s Orzeyful, approved August 5. Narcolepsy type 1 occurs when the brain loses the cells that produce orexin, the neurotransmitter that keeps you awake. Every drug until now has papered over the sleepiness with stimulants. This one replaces the missing signal.
3. The first cholesterol pill in the PCSK9 class. Merck’s Lipfendra, approved July 16. It cuts LDL by 56 to 59%, matching the injectable antibodies, in a daily tablet.
4. The first over-the-counter Tylenol and naproxen combined in one pill. Approved July 24. Faster onset, 12 hours of relief.
5. A herpes virus, engineered to kill cancer, was approved on August 6 for advanced melanoma that stopped responding to immunotherapy. A quarter of those patients responded.
Caveats: The melanoma approval is conditional on a confirmatory trial, and the new cholesterol pill has not yet proven that it prevents heart attacks, only that it lowers the number.
Five firsts. Three weeks. Most of these drugs will be in pharmacies very soon.
🤖 Made with AI
Triathlons are great for producing grit.
🏊♂️🚴🏃@IRONMANtri
Training for an Ironman isn't the same as training your VO₂ max.
An Ironman: 9–14 hours. A VO₂ max test: 8–12 minutes.
One rewards sustained output. The other asks how close to your ceiling you can go.
Both are fitness. Different adaptations.
youtube.com/watch?v=KahsHPVz…
@VO_Health @BrooksLeitner
2
12
482



























